Renjie Gao

Longhua, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Qiling decoction enhances the anti-tumor activity of abiraterone acetate by up-regulating miR-143 expression in abiraterone acetate-resistant prostate cancer cells.

Qiling decoction enhances the anti-tumor activity of abiraterone acetate by up-regulating miR-143 expression in abiraterone acetate-resistant prostate cancer cells.

Journal: Frontiers in medicine

Published: June 09, 2025

The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1-Dependent Autophagy.

The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1-Dependent Autophagy.

Journal: Biotechnology and applied biochemistry

Published: January 08, 2025

Zhoushi Qiling decoction inhibits neuregulin 1 secreted from cancer-associated fibroblasts to ameliorate enzalutamide resistance in prostate cancer.

Zhoushi Qiling decoction inhibits neuregulin 1 secreted from cancer-associated fibroblasts to ameliorate enzalutamide resistance in prostate cancer.

Journal: Journal of traditional and complementary medicine

Published: August 14, 2024

NRG1 secreted by cancer-associated fibroblasts contributes to enzalutamide resistance in prostate cancer cells.

NRG1 secreted by cancer-associated fibroblasts contributes to enzalutamide resistance in prostate cancer cells.

Journal: American journal of cancer research

Published: April 25, 2024

Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway.

Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway.

Journal: Journal of Cancer

Published: April 04, 2023

QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo.

QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo.

Journal: Journal of Cancer

Published: March 16, 2023

JNK promotes the progression of castration-resistant prostate cancer.

JNK promotes the progression of castration-resistant prostate cancer.

Journal: Acta biochimica Polonica

Published: January 11, 2023

Zhoushi Qi Ling decoction inhibits the progression of castration-resistant prostate cancer in vivo by regulating macrophage infiltration via IL6-STAT3 signaling.

Zhoushi Qi Ling decoction inhibits the progression of castration-resistant prostate cancer in vivo by regulating macrophage infiltration via IL6-STAT3 signaling.

Journal: Journal of traditional and complementary medicine

Published: December 15, 2022

miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer.

miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer.

Journal: Journal of Cancer

Published: August 22, 2022

Qi Ling decoction enhances abiraterone treatment via suppression of autophagy in castration resistant prostate cancer.

Qi Ling decoction enhances abiraterone treatment via suppression of autophagy in castration resistant prostate cancer.

Journal: Aging

Published: August 13, 2022

Qi Ling decreases paclitaxel resistance in the human prostate cancer by reversing tumor-associated macrophages function.

Qi Ling decreases paclitaxel resistance in the human prostate cancer by reversing tumor-associated macrophages function.

Journal: Aging

Published: December 02, 2021

Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology.

Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology.

Journal: PeerJ

Published: July 22, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026